792 followers
Characterization of KRAS Mutation Subtypes in Non013small Cell Lung Cancer https://t.co/yf3pe0mMOY
23,708 followers
@JackWestMD @KRASKickers Agreed - but note that the numbers in that study are from Asia, where #KRAS mutations are less common and quite different. In the US, G12C is about 40% of KRAS mutations (see collaboration below with Dr @JJuddOnc et al). https://
486 followers
1,345 followers
Molecular profiles of 17,095 #NSCLC specimens show that KRAS mutation subtypes have different co-occurring mutations and a distinct genomic landscape. The clinical relevance of the difference needs to be investigated. https://t.co/t8xmbz9NLD @JJuddOnc @Ho
156 followers
4,286 followers
1,345 followers
Molecular profiles of 17,095 #NSCLC specimens show that KRAS mutation subtypes have different co-occurring mutations and a distinct genomic landscape. The clinical relevance of the difference needs to be investigated. https://t.co/Ydsq5YIEod @JJuddOnc @Hos
1,345 followers
Molecular profiles of 17,095 #NSCLC specimens show that KRAS mutation subtypes have different co-occurring mutations and a distinct genomic landscape. The clinical relevance of the difference needs to be investigated. https://t.co/x3EVDQZq7O. @JJuddOnc @H
34 followers
1,453 followers
6,266 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
45 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
792 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
33,813 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
7,571 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
34,455 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
684 followers
1,489 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
1,398 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
3,118 followers
RT @StephenVLiu: Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib…
23,708 followers
Available @MCT_AACR: characterization of #KRAS mutation subtypes in NSCLC. With direct KRAS G12C inhibitors like sotorasib and adagrasib, and others in development, granularity of the KRAS landscape is increasingly relevant. @OncoAlert #LCSM https://t.co
7,571 followers
850 followers